Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Apigenin, a flavonoid commonly found in parsley, celery, chamomile, and other plants, has attracted scientific interest for its potential effects on the prostate, particularly regarding prostate cancer. Preclinical studies, primarily in vitro and in animal models, have shown that apigenin may inhibit the proliferation of prostate cancer cells, induce apoptosis (programmed cell death), and suppress tumor growth. Mechanisms proposed include interference with androgen receptor signaling, modulation of cell cycle regulators, and anti-inflammatory effects. For example, research published in journals such as Cancer Letters and Carcinogenesis has demonstrated that apigenin can downregulate proteins involved in cancer cell survival and metastasis.

However, it is important to note that most of the evidence comes from laboratory and animal studies, and there is a lack of robust clinical trials in humans directly evaluating apigenin’s efficacy for prostate health or prostate cancer prevention/treatment. Traditional use of apigenin-containing plants for prostate health is not well documented, and its use in this context is largely driven by emerging scientific findings rather than historical precedent. In summary, while there is promising preclinical scientific evidence suggesting potential benefits of apigenin for the prostate, especially regarding anti-cancer properties, clinical validation in humans is currently limited.

More about Apigenin
More about Prostate

Other ingredients that support Prostate

Other body systems supported by Apigenin

Products containing Apigenin